Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Parsaclisib in Japanese subjects with B-cell lymphoma
NCT03314922Phase 1Completed
- Sponsor
- Incyte
- Start
- Aug 2018
- Primary completion
- May 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial of parsaclisib in B cell lymphoma, sponsored by Incyte. Primary endpoint: Treatment-emergent adverse events at 1 year. Started Aug 2018; status: completed.
02
Drugs
parsaclisib
03
Conditions
B cell lymphoma
Beyond the preview
Go deeper on NCT03314922.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03314922.